Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TyVECO: Typbar-TCV Effectiveness in Kisantu, DRC
NCT05119426Phase 4Unknown
- Sponsor
- International Vaccine Institute
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of typhoid conjugate vaccine in typhoid fever, sponsored by International Vaccine Institute. Status: unknown.
02
Drugs
typhoid conjugate vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT05119426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05119426.